Home / Market News / $PHR
fiscal.ai Corporate Catalyst Impact 75/100 ● negative

JPMorgan Downgrades Phreesia to Underweight From Neutral

Nov 11, 2026, 2:07 PM UTC · Primary ticker $PHR

JPMorgan Chase downgraded Phreesia, Inc. from Neutral to Underweight and set a $13.00 price target. This analyst action signals a more bearish outlook on the healthcare software provider, likely impacting investor sentiment and potentially the stock price.

JPMorgan Chase downgraded Phreesia, Inc. from Neutral to Underweight and established a $13.00 price target. This action by a major investment bank indicates a significant shift in their fundamental view of Phreesia's prospects, suggesting concerns about its future performance or valuation. For traders, this typically translates to short-term negative pressure on the stock as institutional investors may re-evaluate their positions. Long-term implications depend on whether other analysts follow suit or if the company can address the underlying concerns that led to the downgrade. The key risk for traders is further downside if the market broadly adopts this more bearish outlook.

$PHR negative Analyst downgrade and price target reduction
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.